New
Meet us at CILAD* conference in Madrid tomorrow, July 1st at 12 noon, for the discussion of the recent advances in treatment of pigmentary disorders and vitiligo.
Speakers:
- Dr. Gabriel Serrano Sanmiguel MD, PhD, Dermatólogo y fundador de Sesderma Laboratorios
- Dra. Eva Álvarez Roca MD, Asesor médico Sesderma-Mediderma
- Sr. D. Yan Valle, Director ejecutivo Vitiligo Research Fundation. Profesor Asociado de Marconi University
UPDATE: Madrid, Spain is the host not only for NATO summit today, but also a major congress for dermatologists and cosmetologists. Presented the Vitiligo Patient Journey Map to the overcrowded auditorium at Sesderma session. Beginning to change patient/doctor relationship in a life-long diseases like vitiligo. As the Chinese proverb goes, " A thousand miles journey begins with the first step."
* CONCRESO IBERO LATINO-AMERICANO DE DERMATOLOGÍA
FAQOther Questions
- What are risks of oral and topical corticosteroids?
Corticosteroid drugs (like hydrocortisone, and others) are often used for treating vitiligo. By mimicing the effects of hormones your body produces naturally in your adrenal gla...
- How long does it take to treat vitiligo?
Vitiligo, a condition characterized by the loss of skin pigment, can be unpredictable in both progression and treatment. The time it takes to treat vitiligo varies significantly...
- Is it possible to stop the progression of vitiligo?
While it's not always possible to quickly stop vitiligo progression, there are some treatments that can help slow or halt the spread of the condition in many cases: Corticoster...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.